CA2966466C — Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
Assigned to Siga Technologies Inc · Expires 2020-08-25 · 6y expired
What this patent protects
The present invention provides methods of using compounds of formula l and salts thereof to treat infections caused by orthopoxvirus in humans and animals. Also provided are uses of related pharmaceutical compositions in solid unit dosage form. (see formula I)
USPTO Abstract
The present invention provides methods of using compounds of formula l and salts thereof to treat infections caused by orthopoxvirus in humans and animals. Also provided are uses of related pharmaceutical compositions in solid unit dosage form. (see formula I)
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.